Peripheral nerve adjustment for postherpetic neuralgia: a randomized, controlled clinical study.

Area of Science:

• Neurology
• Pain Management
• Physical Therapy

Background:

• Postherpetic neuralgia (PHN) is a chronic neuropathic pain condition following herpes zoster infection.
• Current treatments for PHN have limitations in efficacy and tolerability.
• There is a need for novel therapeutic approaches to manage PHN pain and improve patient outcomes.

Purpose of the Study:

• To evaluate the therapeutic efficacy of peripheral nerve adjustment in patients with postherpetic neuralgia (PHN).
• To assess the impact of peripheral nerve adjustment on pain intensity, quality of life, and medication requirements in PHN patients.

Main Methods:

• A randomized controlled trial involving 102 patients with PHN was conducted.
• Patients were assigned to three groups: peripheral nerve adjustment, sham adjustment, and a control group.
• Pain was assessed using the Visual Analogue Scale (VAS), with quality of life and medication dosage also recorded.

Main Results:

• Peripheral nerve adjustment significantly reduced VAS pain scores compared to control groups (P < 0.05).
• Patients receiving peripheral nerve adjustment showed significant improvements in Quality of Life (QOL) and SF-36 scores, sustained for 180 days.
• The treatment group required lower average dosages of pain medication compared to controls (P < 0.05).

Conclusions:

• Peripheral nerve adjustment is an effective treatment for relieving postherpetic neuralgia (PHN) pain.
• This therapeutic approach improves patients' quality of life and reduces their reliance on pain medication.
• Potential mechanisms include reduced sensitization, modulated nerve plasticity, and increased endogenous analgesia.